Gen Re’s Post

We are proud to have co-published a paper with Pfizer in the Journal of the American Heart Association highlighting the connection between #SDoH and medication adherence in patients with Atrial Fibrillation. The study analyzed adherence associations between community and individual social risk factors and OAC adherence for stroke prevention in AF, and found that social risk factors, such as health literacy, may affect OAC adherence. Read the paper here: https://hubs.la/Q02lG9rL0 #HeartHealthMonth #healthliteracy

4 of the top 7 reasons for #inpatient stays are generally #chronicconditions and treatable, with #depression (#12) and #schizophrenia (#16) among the top 20 diagnoses for inpatient stays. We need to pay more attention to the #mentalhealth side of treatment and #clinicians need more #mentalhealthawareness See #OurTake here: https://lnkd.in/eSFX4gEM

Schizophrenia and alcohol-related disorders were among the top five conditions most commonly associated with readmissions among patients listed as self-pay or no charge, resulting in 18 and 18.7 readmissions respectively for every 100 hospitalizations. Learn more from AHRQ Healthcare Cost and Utilization Project Statistical Brief 307. #PatientCare https://lnkd.in/eGuWRcJX

Schizophrenia and alcohol-related disorders were among the top five conditions most commonly associated with readmissions among patients listed as self-pay or no charge, resulting in 18 and 18.7 readmissions respectively for every 100 hospitalizations. Learn more from AHRQ Healthcare Cost and Utilization Project Statistical Brief 307. #PatientCare https://lnkd.in/eGuWRcJX

A study conducted by AHRQ's Effective Health Care (EHC) Program and published in JAMA concludes that naltrexone and acamprosate can help treat alcohol use disorder (AUD). While both are effective options, naltrexone requires only one pill per day, making it an accessible option that patients are likely to adhere to. Clinicians should engage patients in shared decision making (SDM) when determining the best treatment for AUD. #BetterCare https://bit.ly/3tYrQnU

Today is World Multiple Sclerosis Day. MS is a neurodegenerative disease that can have a significant effect on a patient's quality of life. However, by raising awareness and bringing patients & providers together, people with MS may reduce and manage symptoms to lead more normal lives." #Intrafusion #WorldMultipleSclerosisDay #MultipleSclerosisDay2024 #MS #Healthcare #Medical

Dr. Simarta Brennan-Prescod, a physician, patient, and advocate, shares her unique perspective on living with multiple sclerosis (MS). 🧠 MS is an autoimmune disease, a battle where the body fails to recognize itself and instead, wages war on the nervous system. It's a chameleon of a condition, presenting differently in every individual, making it a challenge to diagnose. 🕵️♀️ Imagine seeing a broken bone. You'd identify it and seek help. But with MS, the journey to diagnosis is often long and winding, with many detours along the way. 🏥 Dr. Brennan-Prescod's experience is threefold. She's not just a physician treating patients, but also a patient herself, and an advocate for others navigating the healthcare system. Her journey with MS is a testament to her resilience and a reminder that every experience, every perspective, adds a layer to our understanding of this complex disease. 🎗️ Remember, no two people with MS look alike. Each journey is unique, and each story adds to the collective narrative. Let's continue to raise awareness and break stereotypes. Repost this if it helped you better understand the complexities of living with multiple sclerosis. With Dr. Simarta Brennan-Prescod: https://lnkd.in/gEcgdG-u #MultipleSclerosisJourney #AutoimmuneDisease #HealthcareAdvocacy

My colleague’s recent article on Musculoskeletal (MSK) conditions links such conditions with other medical and behavioral health comorbidities. Our Chief Medical Officer, Dr. Stella George, highlights advantages of the new Cigna Healthcare Americas and Cigna Healthcare Europe MSK Support Program and how it partners with our other health programs and services to jointly address comorbid conditions. Read our complete article about supporting MSK conditions: https://upl.inc/pjtb2z #MSK #TreatingMSK #CignaHealthcare

We love this resource from HealthCentral Corporation! Inequities in the healthcare system have historically made it difficult for BIPOC individuals to receive the care they deserve, so navigating a diagnosis like MS can be overwhelming. 📌 Bookmark this for flare management guidance and more! https://lnkd.in/gzTg2CQb #msawarenessmonth #msawareness #multiplesclerosis #autoimmunedisease #MS #bipoc #healthequity

Many patients delay seeking diagnosis due to a lack of awareness, and even after diagnosis, many do not adhere to their treatment regimens for various other reasons. This nonadherence can affect quality and length of life, health outcomes, and healthcare costs. According to the National Institutes of Health (NIH), a global mortality rate of 125,000 is attributed to nonadherence. Nonadherence is a multifaceted issue influenced by numerous factors, including socioeconomic status, health literacy, mental health, and the complexity of treatment regimens. Using our scientific approach, we identify the specific needs of each patient and provide them with tailored Patient Support Programs (PSPs). By creating an integrated ecosystem of care and treatment, we ensure that the patients in the access programs we manage receive 360° support, helping them overcome challenges and cope with their disease during their treatment journey. To learn more about our Maximized Adherence solutions, visit: https://lnkd.in/dz_VbZcz #MaximizedAdherenceSolutions #Nonadherence #PatientsFirst